Phase 1 Dose Escalation With Zw25, A Her2-Targeted Bispecific Antibody, In Patients (Pts) With Her2-High Breast Cancer (Bc)
CANCER RESEARCH(2018)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined